Details for New Drug Application (NDA): 050661
✉ Email this page to a colleague
The generic ingredient in IDAMYCIN is idarubicin hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Summary for 050661
Tradename: | IDAMYCIN |
Applicant: | Pfizer |
Ingredient: | idarubicin hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050661
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
Approval Date: | Sep 27, 1990 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/VIAL | ||||
Approval Date: | Sep 27, 1990 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
Approval Date: | Apr 25, 1995 | TE: | RLD: | No |
Complete Access Available with Subscription